513
Participants
Start Date
March 22, 2017
Primary Completion Date
March 16, 2020
Study Completion Date
March 16, 2020
Antimicrobial therapy: Co-trimoxazole or Doxycycline
160mg trimethoprim/800mg sulfamethoxazole (double strength co-trimoxazole) twice daily plus folic acid 5 mg daily OR doxycycline 100mg once daily if weight \< 50 kilograms or 100mg twice daily if weight \> 50 kilograms for up to 36 months
No Intervention: Standard of Care
Standard of care
Columbia University, New York
Weill Cornell Medicine, New York
Albany Medical College, Albany
University of Rochester, Rochester
Pennsylvania State University, Hershey
Temple University, Philadelphia
INOVA, Falls Church
University of Virginia, Charlottesville
University of Alabama at Birmingham, Birmingham
Vanderbilt, Nashville
Ohio State, Columbus
Cleveland Clinic, Cleveland
University of Cincinnati, Cincinnati
University of Michigan, Ann Arbor
Spectrum Health, Grand Rapids
University of Minnesota, Minneapolis
Mayo Clinic, Rochester
Loyola University Chicago, Chicago
Northwestern University, Chicago
University of Chicago, Chicago
University of Kansas, Kansas City
University of Texas at San Antonio, San Antonio
University of Utah, Salt Lake City
University of Arizona, Tucson
Stanford, Stanford
University of California Davis Medical Center, Sacramento
Washington University, Seattle
Massachusetts General Hospital, Boston
Brigham and Women's Hospital, Boston
Beth Israel Deaconess Medical Center, Boston
Dartmouth-Hitchcock Medical Center, Lebanon
Collaborators (1)
Duke Clinical Research Institute
OTHER
University of Chicago
OTHER
University of Washington
OTHER
University of Pittsburgh
OTHER
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Weill Medical College of Cornell University
OTHER